ArticleTranslational andrology and urology2026
Redefining the standard of care for high-risk biochemical recurrence of prostate cancer after definitive therapy: insights from the EMBARK final analysis.
Harutake SawazakiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.